Introduction
Sendai virus is a common murine respiratory pathogen. It is endemic in many colonies of laboratory mice including those of certain highly reputable commercial breeders. It is an interesting virus, because if it is inoculated intranasally into susceptible mice there is no overt manifestation of clinical illness. However, histological and virological examination of inoculated animals reveals that they have experienced an upper respiratory tract infection from which they recover itormally. Sendai virus infection of mice is thus an excellent model of acute respiratory viral infection of man. It is quite different from the adapted influenza infection of mice which induces viral pneumonic illness: a pathology which mercifully is rarely seen in man.
In this paper, some of the studies of Sendai virus infection of mice which have led to and are leading to a better understanding of the pathogenesis of acute respiratory viral infection will be briefly reviewed.
The pathology of the infection
As mentioned above, inoculation of mice with Sendai virus does not produce overt evidence of disease. However, the fact that these inoculated mice are ill can be deduced from the finding that they gain weight at a significantly slower rate than do mock inoculated control mice. Histological examination of lungs removed at intervals after inoculation reveals the characteristic features of acute respiratory viral infection (Robinson, Cureton and Heath, 1968 (Fig. lc) . All of the damaged mucosa is completely repaired by the end of the second week (Fig. Id) . The pathological changes of the airways that are seen in the model system are essentially similar to those caused by influenza in mice (Andrewes, Laidlaw and Smith, 1934) , ferrets (Francis and Stuart-Harris, 1938) and man (Hers, Masurel and Mulder, 1958) .
The remarkable feature of these changes is not the infectious process itself but the fact that it is so abruptly stopped soon after initiation and, in particular, is prevented from extending to involve the whole of the susceptible mucosa. This clearly indicates that respiratory viral infection induces powerful local defence responses, which rapidly bring about its termination. Investigations related to evaluation of these defences will now be briefly described.
Defence against the primary infection Virus growth and both interferon and antibody production occurring during the course of the infection can be determined by assay of serum and suspensions of lungs taken at intervals after inoculation (Robinson et al., 1968) . The data obtained Fig. 3 . The most obvious difference between the disease process in normal and cyclophosphamide-treated mice is the inability of the immunosuppressed animals to eradicate virus from their lungs. The apparent cause of this is the absence of the immune response, which manifests as nonappearance of serum antibody, and also by the histological finding that mononuclear cells do not appear in underlying areas of affected mucosa. In contrast to this, the non-specific defence mechanisms show no diminution but are exaggerated. Interferon production, for example, continues until the death of the animal and inflammatory changes are not only more intense in the submucosa but have now extended to the alveoli. These exaggerated non-specific defence mechanisms on their own are obviously quite incapable of eradicating the virus.
The humoral immune response
The appearance of large numbers of immunoglobulin-containing lymphocytes in the submucosa on the second day of the infection (Blandford et al., 1971), the demonstration that these cells are producing specific antibody by the third day (Blandford and Heath, 1972) (Blandford and Heath, 1974) and the results are summarized in Fig. 4 
